Mammalian bioprocessing is the foundation of biologics production in the pharmaceutical industry. This workshop covers a range of fundamental knowledge spanning the entire drug substance manufacturing process. Students will learn core biological and engineering principles for both cell culture and purification operations. Unit operations for cell culture and purification steps will be described and analyzed. Practical methods for scaling-up manufacturing process will also be described. Additionally, an overview of product quality, analytical, and regulatory topics pertinent to bioprocessing will be provided. Lectures for this workshop are given by industry professionals who will provide insight into how this knowledge is applied to modern biologics production. This detailed yet concise course is appropriate for early to mid-career professionals as well as students looking to gain relevant skills in mammalian bioprocessing. The course is also a great way for individuals in supporting functions such as automation, instrumentation, and supply chain to gain a deeper understanding of the manufacturing processes they support.
This section is the full week of cell culture bioprocessing. Please note that there are separate 3-day options for only Upstream or Downstream during the same week.
- Cary Opel, Senior Scientist, Gilead Sciences, Inc.
- Antonio Grillo-Lopez, Former CMO, IDEC
- Daniel Gibbs, Director, Salk Institute
- Eric Fallon, Director, Genentech
- Kara Calhoun, Director, Genentech
- Julio Baez, Former CSO, Cipla BioTec
- Tom Fletcher, Scientific Director, Fujifilm Irvine Scientific
- Nathan Lewis, Associate Professor, UC San Diego
Note: This workshop will take place at Gilead Sciences, Inc., in Oceanside, CA, and is open to attendees over 18 years of age. Closed-toe shoes are required at all times.
Course Number: BIOL-40349
Credit: 4.00 unit(s)
+ Expand All
9/16/2019 - 9/20/2019